CorMedix Inc CRMD:NASDAQ

Last Price$4.02NASDAQ Previous Close - Last Trade as of 4:00PM ET 8/18/22

Today's Change0.00(0.00%)
Bid (Size)$3.96 (1)
Ask (Size)$4.06 (1)
Day Low / High$3.96 - 4.12
Volume303.1 K
 

View Biotechnology IndustryPeer Comparison as of 08/18/2022

 

CorMedix Inc ( NASDAQ )

Price: $4.02
Change: 0.00 (0.00%)
Volume: 303.1 K
4:00PM ET 8/18/2022
 
 

INmune Bio Inc ( NASDAQ )

Price: $9.02
Change: -0.06 (0.66%)
Volume: 43.2 K
4:00PM ET 8/18/2022
 
 

AVITA Medical Inc ( NASDAQ )

Price: $6.92
Change: +0.09 (1.32%)
Volume: 76.7 K
4:00PM ET 8/18/2022
 
 

La Jolla Pharmaceutical Co ( NASDAQ )

Price: $6.22
Change: +0.05 (0.81%)
Volume: 341.0 K
4:00PM ET 8/18/2022
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

--Truist Securities Lowers CorMedix's Price Target to $16 From $27, Maintains Buy Rating
10:46AM ET 8/12/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (CRMD) CORMEDIX Posts Q2 Revenue $21,253
7:31AM ET 8/11/2022 MT Newswires

...

Top Midday Decliners
1:59PM ET 8/09/2022 MT Newswires

Norwegian Cruise Line Holdings (NCLH) slumped more than 11% amid heavy trading after the company reported a narrower loss in Q2 that missed the market's...

--JMP Securities Adjusts CorMedix Price Target to $14 From $19, Maintains Market Outperform Rating
11:14AM ET 8/09/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Company Profile

Business DescriptionCorMedix, Inc. operates as a pharmaceutical and medical device company. The firm seeks to license, develop and commercialize prophylactic and therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It is developing its product Neutrolin, a novel, non-antibiotic antimicrobial solution designed to prevent costly and dangerous bloodstream infections associated with the use of central venous catheters. The company was founded by Antony E. Pfaffle in 2006 and is headquartered in Berkeley Heights, NJ. View company web site for more details
Address300 Connell Drive
Berkeley Heights, New Jersey 07922
Phone+1.908.517.9500
Number of Employees22
Recent SEC Filing08/11/202210-Q
Chief Executive Officer & DirectorJoseph Todisco
Chief Financial Officer & Executive Vice PresidentMathew T. David
Secretary & Chief Scientific OfficerAntony E. Pfaffle
Executive VP-Clinical & Medical AffairsElizabeth Masson-Hurlburt

Company Highlights

Price Open$4.00
Previous Close$4.02
52 Week Range$2.65 - 8.03
Market Capitalization$165.3 M
Shares Outstanding41.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement11/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.80
Beta vs. S&P 500N/A
Revenue$429.8 K
Net Profit Margin-25,126.35%
Return on Equity-48.87%

Analyst Ratings as of 08/26/2021

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset